AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
AstraZeneca and Indian Society of Nephrology aim to help clinicians and healthcare practitioners to provide holistic kidney care to their patients.
Desidustat is currently approved only in India as OxemiaTM for patients with CKD induced anemia
Under this year’s theme of ‘Kidney Health For All’, ISN along with AstraZeneca aims to generate large scale awareness and educate people about ways to improve kidney health
Tolvaptan is indicated to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease
Experts urge early detection & better access to care
EBITDA at Rs. 250 crore, up 47% YoY, with 35% EBITDA margin
Commercial terms include research funding and milestones and/or royalty payments to Evotec based on the success of the program
IgAN is a heterogeneous, progressive, rare kidney disease and is a major cause of chronic kidney disease worldwide
AIIMS Rewari is a 750-bed hospital complex which includes a 100 seat medical college, a 60 seat nursing college, a 30-bed AYUSH block
Subscribe To Our Newsletter & Stay Updated
